Activate Now
ProHealth fibromyalgia Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Aromatherapy Diffusers For Fibromyalgia Support

Chronic Fatigue Syndrome, Fibromyalgia and Mitchondrial Disorders: A Comparison Plus the MitoQ Trial...

Dr. Teitelbaum's 3 Steps to Fibromyalgia Pain Relief - Part 1: Understanding Fibromyalgia Pain

An Interview with Ken McKim: Educating the public about chronic illness

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

Milnacipran for pain in fibromyalgia in adults

Are All the "Feel-Good" Pathways Blocked in Fibromyalgia and Chronic Fatigue Syndrome?

5 Things I've Learned About Chronic Illness Through Mindfulness

SURVEY RESULTS: Has Your Illness Affected What You Eat?

Staying healthy from fibromyalgia is ongoing hard work

Print Page
Email Article

Has Workwell Foundation Identified a Diagnostic Biomarker for Chronic Fatigue Syndrome?

  [ 13 votes ]   [ Discuss This Article ] • September 3, 2013

Press Release: Workwell Foundation, August 8, 2013

New Study by Workwell Foundation Demonstrates Diagnostic Value of 2-Day Test Protocol Ripon, CA. August 8, 2013 - Workwell Foundation announces the publication of a new study supporting previous findings that a 2-day Cardiopulmonary Exercise Test (CPET) protocol objectively documents post-exertional malaise (PEM), the most commonly recognized symptom in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

The study revealed a statistically significant performance decrease on Day 2 in workload at ventilatory threshold (VTWL), workload at peak exercise (WLpeak), volume of oxygen consumed at ventilatory threshold (VTO2) and volume of oxygen consumed at peak exercise (VO2peak). In short, individuals with CFS/ME were unable to reproduce their Day 1 performance on Day 2. The statistical classification analysis points to a diagnostic biomarker for CFS/ME with a 95.1% accuracy.

The study “Discriminative Validity of Metabolic and Workload Measurements to Identify Individuals with Chronic Fatigue Syndrome” was published on June 27th in the Physical Therapy Journal (PTJ). The statistical analysis correctly classified 49 of 51 CFS/ME patients and 9 of 10 matched, non-disabled, sedentary individuals based on 2-day CPET.

Staci Stevens, the study’s co-author and Program Director at Workwell Foundation, developed the 2-day CPET protocol. She states it “provides the CFS/ME community an objective, quantitative marker of post exertional malaise. To date, diagnosis has been qualitative based on a list of symptoms, resulting in wide variability in the patient population.”

Workwell who pioneered the use of the 2-day test states there are some mandatory features of their protocol: (1) two identical tests, separated by 24 hours; (2) collection of gas exchange data; and (3) use of bicycle ergometry to accurately measure work output. Results from a single CPET can be misinterpreted as deconditioning and can lead to an exercise prescription that is inappropriate for CFS/ME patients. The objective measurements in CPET, including indicators of maximal effort, remove issues of self-report bias and the question of effort – the test cannot be faked.

Who Benefits?

Patients: Workwell’s 2-day CPET provides patients with a functional assessment based on objective measurements. Knowledge of their ventilatory threshold allows them to pace their activities by wearing a heart rate monitor, an effective intervention to reduce PEM.

Physical Therapists: Can develop appropriate activity management programs using results of the 2-day CPET. VT often occurs at very low levels of oxygen consumption and workload. Normal activities of daily living may exceed a patients VT necessitating very limited and gradual activity interventions.

Medical Researchers: Clinical trials that employ Workwell’s CPET protocol to qualify study participants and to measure outcomes, reduce confounding problems of patient heterogeneity that have hampered CFS/ME research for years.

Attorneys: Can use the functional assessment of 2-day CPET to provide objective clinical evidence disability.

What Are The Next Steps in Research?

This study proposes key future research directions including exercise test protocol selection and the inclusion of lactate measurement as an additional validation of VT. While the etiology of PEM in CFS/ME remains unclear, this study moves the field forward.

About Workwell Foundation

Workwell specializes in the evaluation of disability for individuals with CFS/ME, Fibromyalgia Syndrome (FMS), and other fatiguing conditions. CPET is the gold standard for determining disability. Workwell employs their unique 2-day protocol to support diagnoses and document the disabling consequences of physical activity, including post-exertional malaise (PEM) and symptom exacerbation. The objective measures taken accurately assess an individual’s capacity for work. Visit Workwell Foundation

Citations: Christopher R. Snell, Staci R. Stevens, Todd E. Davenport and J. Mark VanNess. (2013). Discriminative Validity of Metabolic and Workload Measurements to Identify Individuals with Chronic Fatigue Syndrome. PHYS THER.Published online June 27, 2013 doi: 10.2522/ptj.20110368.

Phone: 209.599.7194 P.O. Box 1435

Fax: 209.599.4047 Ripon, CA 95366


Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ B-12 Extreme™ Guaifenesin FA™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Subscribe Now!
Receive up-to-date ME/CFS, Fibromyalgia & Lyme Disease treatment and research news
 Privacy Guaranteed  |  View Archives

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

Featured Products

Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 your brain needs for detox & sharpness
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Guaifenesin FA™ Guaifenesin FA™
Helps the Body Eliminate Excess Calcium and Phosphates
Fibro Freedom™ Fibro Freedom™
Soothes, strengthens & revitalizes
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Reversing Neurodegeneration with a New Magnesium Compound Reversing Neurodegeneration with a New Magnesium Compound
Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health

What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Causes
Fibromyalgia Treatments
Fibromyalgia Diet
Fibromyalgia Medications
M.E. & CFS
What is M.E./CFS?
M.E./CFS Diagnosis
M.E./CFS Symptoms
M.E./CFS Causes
M.E./CFS Treatments
M.E./CFS Diet
M.E./CFS Medications
What is Lyme Disease?
Lyme Disease Diagnosis
Lyme Disease Symptoms
Lyme Disease Causes
Lyme Disease Treatments
Lyme Disease Diet
Lyme Disease Medications
M.E. & CFS
Lyme Disease
General Health
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing